FDA
approval
· 2022-04-29
FDA Approved: NORELGESTROMIN AND ETHINLY ESTRADIOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
Summary
The FDA approved a supplemental application for the generic combined oral contraceptive product NORELGESTROMIN AND ETHINLY ESTRADIOL from Amneal Pharmaceuticals…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORELGESTROMIN AND ETHINLY ESTRADIOL (NORELGESTROMIN AND ETHINLY ESTRADIOL)